DrugMar 8, 2017
Zenatane (isotretinoin) capsules, 20 mg recall — FDA D-0507-2017
Failed dissolution specifications - low dissolution results at S3 stage.
Class IIIFDA: TerminatedDr. Reddy's Laboratories, Inc.
Recall history in this database
Classification mix: Class II: 50, Class III: 33, Class I: 3.
DrugFeb 15, 2017
Olanzapine tablets, USP, 2.5 mg recall — FDA D-0468-2017
Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.
Class IIIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugJul 6, 2016
Dr. Reddy's Laboratories CVS pharmacy Original Strength Acid Controller tablets, 10 mg recall — FDA D-1058-2016
Failed impurities/degradation specification: An out of specification results has been determined for an individual related substance during stability testing at the 18th month interval for…
Class IIIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugApr 6, 2016
Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL), 100 mL Single Use Bottle recall — FDA D-0784-2016
Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugSep 2, 2015
Amlodipine besylate and Atorvastatin calcium Tablets, 10 mg/20 mg recall — FDA D-1377-2015
Subpotent Drug: Subpotent atorvastatin.
Class IIIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugSep 2, 2015
Amlodipine besylate and Atorvastatin calcium Tablets, 5 mg/20 mg recall — FDA D-1376-2015
Subpotent Drug: Subpotent atorvastatin.
Class IIIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugSep 2, 2015
Amlodipine besylate and Atorvastatin calcium Tablets,10 mg/40 mg recall — FDA D-1378-2015
Subpotent Drug: Subpotent atorvastatin.
Class IIIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugJun 24, 2015
Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count recall — FDA D-1135-2015
Failed Dissolution Specifications; exceeded specification at the 9 hour time point
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugMar 12, 2014
Dr. Reddy's Laboratories a) Walgreens Lansoprazole Delayed Release Capsules, USP 15 mg/Acid recall — FDA D-1146-2014
Microbial Contamination of Non-Sterile Products: Out-of-specification results for microbial count were observed at the initial stability interval for Lansoprazole Delayed Release Capsules.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugSep 25, 2013
IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) recall — FDA D-1042-2013
Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugAug 21, 2013
Dr. Reddy's Laboratories Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC, a) Equate brand recall — FDA D-884-2013
Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugNov 28, 2012
Dr. Reddy's Laboratories Dr. Reddy's Quetiapine Fumarate Tablets, 25mg recall — FDA D-059-2013
Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugAug 8, 2012
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Dr. Reddy's Amlodipine Besylate and recall — FDA D-1434-2012
Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and…
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugAug 8, 2012
Dr. Reddy's Laboratories Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets recall — FDA D-1435-2012
Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and…
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Dr. Reddy's Laboratories, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.